Khosla Ventures

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, a co-founder of Sun Microsystems. Based in Menlo Park, California, the firm manages over $5 billion and primarily invests in early-stage technology companies throughout the United States. Khosla Ventures provides capital, strategic advice, and venture assistance to entrepreneurs focused on breakthrough innovations across various sectors, including consumer technology, enterprise solutions, health, education, agriculture, and sustainable energy. The firm has a particular interest in high-risk, high-reward opportunities, often acting as a sole investor in "science or innovation experiments." Investment sizes typically range from $100,000 to over $20 million, allowing Khosla Ventures to support both traditional ventures and unconventional projects.

Bruce Armstrong

Operating Partner

Irene Au

Angel

Ryno Blignaut

Operating Partner

Alice Brooks

Partner

Peter Buckland

Partner, Managing Director and COO

Benny Buller

Investment Professional

Brian Byun

Operating Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner

Kanu Gulati

Partner

Emmanuel T. Hernandez

Operating Partner

Judy Huang

Operating Partner

Keith Janosky

Chief Financial Officer and Head of Investor Relations

Jun Jeon

Principal

Samir Kaul

Founding Partner & Managing Director

Paul Kirincich

Operating Partner

Alexander A. Morgan

Partner

Alexander Morgan Ph.D

Partner

Hesam Motlagh

Chief of Staff

Keith Rabois

Managing Director

Jessy Rivest Ph.D

Partner

Nikita Shamgunov

Partner & Investor

Sven Strohband Ph.D

Managing Director

Rajesh Swaminathan

Partner

Adina Tecklu

Partner

Sandhya Venkatachalam

Partner

David Weiden

Founding Partner and Managing Director

Ece Wyrick

Principal

Past deals in New England

Volta Labs

Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on engineering and developing tools for biological automation. Founded in 2018, the company specializes in creating scalable automation solutions for genetic engineering, aiming to enhance efficiency and precision in biological research and applications.

Scipher Medicine

Series D in 2022
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.

Cellino

Series A in 2022
Cellino Biotech, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in developing intracellular delivery lasers and nanotechnology for gene editing applications. By leveraging advanced tools from optics, biology, and computation, Cellino transforms the process of stem cell differentiation into a digital format, allowing for the engineering of functionally mature cells. This innovative approach significantly accelerates the development time of engineered cells, reducing it from years to weeks.

Nabla Bio

Seed Round in 2021
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities.Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.

Vicarious Surgical

Post in 2021
Vicarious Surgical Inc. is a company based in Charlestown, Massachusetts, that specializes in developing virtual reality software designed for minimally invasive surgical procedures. The company has created a surgical system that integrates virtual reality technology with robotic systems, allowing surgeons to perform operations with enhanced precision and control. Founded in 2014, Vicarious Surgical aims to improve surgical outcomes and patient recovery times through innovative technology.

Lula

Series A in 2021
Lula operates a peer-to-peer marketplace that connects vehicle owners with individuals seeking to rent those vehicles. It allows vehicle owners to list their vehicles for rent and facilitates direct communication and transactions between owners and renters. Lula does not own or manage the vehicles and does not engage in the contracts formed between owners and renters. Additionally, Lula provides insurance technology solutions tailored for various sectors, including car rental companies and logistics firms. Their offerings include policy management, risk assessment tools, and claims handling services, which help clients streamline their insurance processes and reduce operational costs.

Catch

Venture Round in 2021
Catch is a Boston-based company that designs a personal benefits platform aimed at freelancers, contractors, and workers without employer-sponsored benefits. Established in 2016, Catch provides a range of financial solutions, including tax withholding, retirement savings plans, health insurance, and student loan refinancing. The platform allows users to conduct benefit checkups, link bank accounts, and create personalized financial plans, helping individuals build a comprehensive safety net for their financial stability and security. By leveraging data-driven insights, Catch enables users to take control of their financial needs and manage their wealth effectively in an evolving work landscape.

Scipher Medicine

Series C in 2021
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.

Cellino

Seed Round in 2021
Cellino Biotech, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in developing intracellular delivery lasers and nanotechnology for gene editing applications. By leveraging advanced tools from optics, biology, and computation, Cellino transforms the process of stem cell differentiation into a digital format, allowing for the engineering of functionally mature cells. This innovative approach significantly accelerates the development time of engineered cells, reducing it from years to weeks.

SiPhox Inc.

Seed Round in 2020
SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests for disease safely and in a disposable point-of-care and at-home manner. SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.

Vicarious Surgical

Series A in 2020
Vicarious Surgical Inc. is a company based in Charlestown, Massachusetts, that specializes in developing virtual reality software designed for minimally invasive surgical procedures. The company has created a surgical system that integrates virtual reality technology with robotic systems, allowing surgeons to perform operations with enhanced precision and control. Founded in 2014, Vicarious Surgical aims to improve surgical outcomes and patient recovery times through innovative technology.

Commonwealth Fusion

Series A in 2020
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

E25Bio

Venture Round in 2020
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Iora Health

Series F in 2020
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Ori

Series B in 2019
Ori is a smart space company that empowers people to get the most out of their living areas through the design of multi-functional, robotic-powered interior solutions. We partner with real estate developers, builders, property managers, and architects to optimize the square footage of the built environments they shape in order to create urban housing and spaces that are flexible, intelligent, sustainable and affordable. We believe we should expect more from our spaces.

Commonwealth Fusion

Series A in 2019
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

Cellino

Venture Round in 2019
Cellino Biotech, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in developing intracellular delivery lasers and nanotechnology for gene editing applications. By leveraging advanced tools from optics, biology, and computation, Cellino transforms the process of stem cell differentiation into a digital format, allowing for the engineering of functionally mature cells. This innovative approach significantly accelerates the development time of engineered cells, reducing it from years to weeks.

Catch

Seed Round in 2019
Catch is a Boston-based company that designs a personal benefits platform aimed at freelancers, contractors, and workers without employer-sponsored benefits. Established in 2016, Catch provides a range of financial solutions, including tax withholding, retirement savings plans, health insurance, and student loan refinancing. The platform allows users to conduct benefit checkups, link bank accounts, and create personalized financial plans, helping individuals build a comprehensive safety net for their financial stability and security. By leveraging data-driven insights, Catch enables users to take control of their financial needs and manage their wealth effectively in an evolving work landscape.

Vicarious Surgical

Series B in 2019
Vicarious Surgical Inc. is a company based in Charlestown, Massachusetts, that specializes in developing virtual reality software designed for minimally invasive surgical procedures. The company has created a surgical system that integrates virtual reality technology with robotic systems, allowing surgeons to perform operations with enhanced precision and control. Founded in 2014, Vicarious Surgical aims to improve surgical outcomes and patient recovery times through innovative technology.

Scipher Medicine

Series A in 2018
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.

Spyce

Series A in 2018
Spyce is an original restaurant concept featuring a robotic kitchen that cooks and serves delicious meals. It is an intersection of technology and hospitality, making cravable or tasty and nutritious food at a broadly accessible price point. Spyce was founded in 2015 and is headquartered in Somerville, MA, USA.

Digital Alloys

Series B in 2018
Digital Alloys, Inc. is a company specializing in the development and manufacturing of metal 3D printers, focusing on high-speed, multi-metal additive manufacturing systems. Founded in January 2017 as a spinout from New Valence Robotics, the company is based in Burlington, Massachusetts. Digital Alloys' technology allows for the printing of production-quality parts using various metals at significantly lower costs compared to traditional systems. This capability enables the mixing of multiple metals within a single component, allowing customers to explore innovative designs and create products with enhanced thermal, electrical, magnetic, and mechanical properties. The company is supported by an experienced management team and backed by Khosla Ventures, positioning it to expand the applications of metal 3D printing across various industries.

Artrendex

Venture Round in 2018
Artrendex, Inc., founded in 2016 and located in East Windsor, New Jersey, offers artificial intelligence solutions designed to assist artists, galleries, and collectors in realizing their goals. The company specializes in quantifying aesthetic concepts, traditionally viewed as subjective, through advanced visual analytics. Its innovative models can predict style changes and trends based on historical data, addressing the needs of a substantial art market valued at over $64 billion. As much of this market consists of art purchased as an investment, Artrendex provides essential data-analytics tools that help assess the potential value of artworks.

Ten Percent Happier

Seed Round in 2018
Ten Percent Happier is a provider of a meditation platform designed for fidgety skeptics. The company's platform offers expert advice to monitor behavioral changes in a person's life by blending text messages, web content, and short videos that enables users to access a clear a simple approach to meditation. It was founded in 2013 and is headquartered in Boston, Massachusetts.

Iora Health

Series E in 2018
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

Vicarious Surgical

Series A in 2018
Vicarious Surgical Inc. is a company based in Charlestown, Massachusetts, that specializes in developing virtual reality software designed for minimally invasive surgical procedures. The company has created a surgical system that integrates virtual reality technology with robotic systems, allowing surgeons to perform operations with enhanced precision and control. Founded in 2014, Vicarious Surgical aims to improve surgical outcomes and patient recovery times through innovative technology.

Twine Health

Series A in 2017
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool. The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more. Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.

Ori

Series A in 2017
Ori is a smart space company that empowers people to get the most out of their living areas through the design of multi-functional, robotic-powered interior solutions. We partner with real estate developers, builders, property managers, and architects to optimize the square footage of the built environments they shape in order to create urban housing and spaces that are flexible, intelligent, sustainable and affordable. We believe we should expect more from our spaces.

Mainspring

Series C in 2017
Mainspring designs and develops digital business strategies. The company provides consulting services focusing on digital technologies, business optimization, and technology enablement. Mainspring, formerly known as Mainspring Communications Inc., was founded in 1996 and is based in Cambridge, Massachusetts.

Twine Health

Series A in 2017
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool. The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more. Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.

Digital Alloys

Series A in 2017
Digital Alloys, Inc. is a company specializing in the development and manufacturing of metal 3D printers, focusing on high-speed, multi-metal additive manufacturing systems. Founded in January 2017 as a spinout from New Valence Robotics, the company is based in Burlington, Massachusetts. Digital Alloys' technology allows for the printing of production-quality parts using various metals at significantly lower costs compared to traditional systems. This capability enables the mixing of multiple metals within a single component, allowing customers to explore innovative designs and create products with enhanced thermal, electrical, magnetic, and mechanical properties. The company is supported by an experienced management team and backed by Khosla Ventures, positioning it to expand the applications of metal 3D printing across various industries.

Vicarious Surgical

Venture Round in 2016
Vicarious Surgical Inc. is a company based in Charlestown, Massachusetts, that specializes in developing virtual reality software designed for minimally invasive surgical procedures. The company has created a surgical system that integrates virtual reality technology with robotic systems, allowing surgeons to perform operations with enhanced precision and control. Founded in 2014, Vicarious Surgical aims to improve surgical outcomes and patient recovery times through innovative technology.

Iora Health

Series D in 2016
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

Spyce

Seed Round in 2016
Spyce is an original restaurant concept featuring a robotic kitchen that cooks and serves delicious meals. It is an intersection of technology and hospitality, making cravable or tasty and nutritious food at a broadly accessible price point. Spyce was founded in 2015 and is headquartered in Somerville, MA, USA.

AVA

Seed Round in 2016
AVA, Inc. provides a messaging-based eating platform that transforms the way people think about food and nutritional health. Its platform provides the way to keep track of the choices, determine the calories in the meal, and provide personalized recommendations for future meals. The company was founded in 2016 and is based in Boston, Massachusetts. As of November 19, 2019, AVA, Inc. operates as a subsidiary of Koninklijke DSM N.V.

Twine Health

Series A in 2015
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool. The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more. Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.

Editas Medicine

Series B in 2015
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. The company has generated substantial patent filings and has access to intellectual property covering foundational genome editing technologies, as well as essential advancements and enablements that will uniquely allow the company to translate early findings into viable human therapeutic products. Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. It was founded in 2013 and is headquartered in Cambridge, Massachusetts, the United States with a growing site in Boulder, Colorado.

SES

Series B in 2015
SolidEnergy Systems Corp. specializes in the development and manufacturing of rechargeable lithium metal batteries, targeting applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and located in Woburn, Massachusetts, the company operates at a pilot scale to produce rechargeable cells for prototype demonstrations and niche aerospace markets. SolidEnergy's core innovation lies in the materials it provides, specifically anodes and electrolytes, which are designed for integration with existing lithium-ion cell manufacturing processes. This compatibility enables the company to scale its production without the need for significant investment in new infrastructure. By supplying these materials to major lithium-ion cell manufacturers, SolidEnergy facilitates the creation of customized battery solutions for a variety of applications, positioning itself for growth in the mainstream consumer electronics and electric vehicle markets.

Iora Health

Series C in 2015
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

Quantopian

Series B in 2014
Quantopian, Inc. operates an online platform for developing and testing quantitative trading algorithms. Its platform provides tools and infrastructure for users to learn about quantitative finance by joining the community discussions and exploring algorithms that other members have shared; create and backtest algorithms; review results and risk metrics; and trade their algorithmic strategies. Quantopian, Inc. was incorporated in 2011 and is based in Boston, Massachusetts.

EyeNetra

Series A in 2014
EyeNetra, Inc. is a company based in Somerville, Massachusetts, founded in 2011, that specializes in developing and manufacturing eye diagnostic tools, including auto-refractors and lens-meters. Its innovative platform leverages smartphone technology to enable users to conduct their own eye tests, measuring conditions such as nearsightedness, farsightedness, and astigmatism. EyeNetra's products, including the NETRA autorefractor and lensometer, facilitate quick and accurate refractive measurements necessary for eyeglass prescriptions. In addition, the company offers the Insight Portal, which enhances electronic medical record (EMR) systems by providing a comprehensive solution for managing patients and mobile clinics globally. This user-friendly approach aims to improve access to eye care and streamline the diagnostic process for both patients and eye care professionals.

Ambri

Series C in 2014
Ambri, Inc. (formerly Liquid Metal Battery Corporation (LMBC)) is an early-stage company working to develop and commercialize a new battery technology that will revolutionize grid-scale power storage. Their battery has the potential to cost significantly less than existing batteries. By decoupling power supply and power demand, the liquid metal battery will be a major enabler of the widespread use of sustainable energy sources and the development of more efficient power systems. Ambri was founded in 2010 and is headquartered in Marlborough, Massachusetts, United States.

Quantopian

Series A in 2013
Quantopian, Inc. operates an online platform for developing and testing quantitative trading algorithms. Its platform provides tools and infrastructure for users to learn about quantitative finance by joining the community discussions and exploring algorithms that other members have shared; create and backtest algorithms; review results and risk metrics; and trade their algorithmic strategies. Quantopian, Inc. was incorporated in 2011 and is based in Boston, Massachusetts.

Berkshire Grey

Series A in 2013
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Sand 9

Series C in 2012
Sand 9, Inc. is a venture-funded startup focused on designing components that enhance the performance and capabilities of wireless devices. The company specializes in MEMS timing products that cater to both wired and wireless systems across various sectors, including communications, industrial, military, and mobile markets. By developing innovative solutions, Sand 9 aims to significantly improve the functionality of devices, positioning itself as a key player in the evolving landscape of technology.

Ambri

Series B in 2012
Ambri, Inc. (formerly Liquid Metal Battery Corporation (LMBC)) is an early-stage company working to develop and commercialize a new battery technology that will revolutionize grid-scale power storage. Their battery has the potential to cost significantly less than existing batteries. By decoupling power supply and power demand, the liquid metal battery will be a major enabler of the widespread use of sustainable energy sources and the development of more efficient power systems. Ambri was founded in 2010 and is headquartered in Marlborough, Massachusetts, United States.

Sand 9

Series B in 2010
Sand 9, Inc. is a venture-funded startup focused on designing components that enhance the performance and capabilities of wireless devices. The company specializes in MEMS timing products that cater to both wired and wireless systems across various sectors, including communications, industrial, military, and mobile markets. By developing innovative solutions, Sand 9 aims to significantly improve the functionality of devices, positioning itself as a key player in the evolving landscape of technology.

Mascoma

Series C in 2008
Mascoma Corporation was founded in late 2005 with initial funding from Khosla Ventures and Flagship Ventures in early 2006. A Series B round of funding was closed in November of 2006 and a Series C round of funding was closed in May of 2008. They wish to replace the use of gasoline with cellulosic ethanol.

Sand 9

Series A in 2008
Sand 9, Inc. is a venture-funded startup focused on designing components that enhance the performance and capabilities of wireless devices. The company specializes in MEMS timing products that cater to both wired and wireless systems across various sectors, including communications, industrial, military, and mobile markets. By developing innovative solutions, Sand 9 aims to significantly improve the functionality of devices, positioning itself as a key player in the evolving landscape of technology.

Lumenz

Venture Round in 2008
LumenZ, Inc is a Boston-based opto-electronic and efficient LED company. If you have any further information about this company, please build out the profile by clicking [here](/organization/lumenz-in/edit_overview).

Sand 9

Seed Round in 2007
Sand 9, Inc. is a venture-funded startup focused on designing components that enhance the performance and capabilities of wireless devices. The company specializes in MEMS timing products that cater to both wired and wireless systems across various sectors, including communications, industrial, military, and mobile markets. By developing innovative solutions, Sand 9 aims to significantly improve the functionality of devices, positioning itself as a key player in the evolving landscape of technology.

Codon Devices

Series B in 2006
Codon Devices is a biotechnology company, engages in developing, constructing, and delivering synthetic biology products for research. The company focuses on discovering and manufacturing synthetic biological parts. Its BioLOGIC Engineering Platform combines sophisticated design algorithms with assay and protein engineering capabilities to result in a system for the design, discovery, and optimization of proteins for specific applications; and BioFAB Production Platform, which produces synthetic genes.

Mascoma

Series B in 2006
Mascoma Corporation was founded in late 2005 with initial funding from Khosla Ventures and Flagship Ventures in early 2006. A Series B round of funding was closed in November of 2006 and a Series C round of funding was closed in May of 2008. They wish to replace the use of gasoline with cellulosic ethanol.

Mascoma

Series A in 2006
Mascoma Corporation was founded in late 2005 with initial funding from Khosla Ventures and Flagship Ventures in early 2006. A Series B round of funding was closed in November of 2006 and a Series C round of funding was closed in May of 2008. They wish to replace the use of gasoline with cellulosic ethanol.

GreatPoint Energy

Series B in 2006
GreatPoint Energy, Inc. specializes in producing pure hydrogen and substitute natural gas through a proprietary catalytic hydromethanation process that converts carbon-rich feedstocks, including coal, petroleum coke, and biomass. This process not only generates a methane-rich gas stream suitable for various applications, such as residential and commercial heating, power generation, and industrial uses, but also allows for the capture and sequestration of carbon dioxide. The company's technology results in low-cost, clean, pipeline-quality natural gas with a minimal environmental impact. Additionally, GreatPoint Energy produces valuable by-products, including vanadium, nickel, activated carbon, ammonia, and sulfuric acid. The company serves clients across several countries, including China, South Korea, Japan, Taiwan, and Indonesia. Founded in 2004 and headquartered in Cambridge, Massachusetts, GreatPoint Energy collaborates with strategic investors and partners such as AES Corp, Dow Chemical, Peabody Energy, and Suncor Energy.